Protein kinase A governs growth and virulence in Candida tropicalis

Chi-Jan Lin1, Chia-Yen Wu1, Shang-Jie Yu1

  • 1a Department of Plant Pathology and Microbiology , National Taiwan University , Taipei , Taiwan.

Virulence
|December 20, 2017
PubMed

Insights

The protein kinase A (PKA) pathway is crucial for Candida tropicalis virulence. Tpk1 regulates drug tolerance and cell wall integrity, while Tpk2 controls dimorphism and adhesion, with both essential for growth and infection.

Area of Science:

  • Medical Mycology
  • Molecular Biology
  • Pathogen Virulence

Background:

  • Candida tropicalis is a significant human fungal pathogen causing superficial and systemic infections.
  • The cyclic AMP/protein kinase A (cAMP/PKA) pathway regulates virulence factors like adhesion and dimorphism in Candida albicans.
  • Limited research exists on the PKA pathway's role in Candida tropicalis.

Purpose of the Study:

  • To investigate the roles of Tpk1 and Tpk2, the catalytic subunits of PKA, in Candida tropicalis.
  • To determine their involvement in fungal growth, cell wall integrity, drug tolerance, and virulence.

Main Methods:

  • Gene deletion to create tpk1/tpk1, tpk2/tpk2, and tpk1/tpk1 tpk2/tpk2 mutants.
  • Assessment of hyphal growth, adhesion, and biofilm formation.
  • Evaluation of virulence in a murine model of systemic infection.
  • Analysis of gene expression for virulence factors (EFG1, HWP1, BCR1, FLO8, GAL4, RIM101).

Main Results:

  • Tpk1 is involved in cell wall integrity and drug tolerance.
  • tpk2/tpk2 mutants exhibited reduced hyphal growth and adhesion.
  • The double deletion mutant showed delayed growth and impaired hyphal formation.
  • Both TPK1 and TPK2 are essential for full virulence in a systemic infection model.
  • PKA regulates EFG1 and HWP1 expression, while BCR1, FLO8, GAL4, and RIM101 are upregulated in the double mutant.

Conclusions:

  • Tpk1 plays a role in drug tolerance and cell wall integrity in C. tropicalis.
  • Tpk2 is a key regulator of dimorphism and adhesion.
  • Both Tpk1 and Tpk2 are necessary for C. tropicalis growth and virulence.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.7K